UNSPSC 51283222: Spiramycin i

This classification denotes a macrolide antibiotic C43H74N2O14, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 033ECH6IFG, chemically known as leucomycin v, 9-o-((2r,5s,6r)-5-(dimethylamino)tetrahydro-6-methyl-2h-pyran-2-yl)-, but more generally known as spiramycin i, which bears US NIH Compound Identifier 158334. Most nations, for tariff and trade purposes, schedule spiramycin i under HS 29419000 and SITC 54139. As of Q4 2014, SPIRAMYCIN I remains US FDA's Preferred Term for this commodity.

SMILES: C[C@@H]1C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)O)N(C)C)O)CC=O)C)O[C@H]4CC[C@@H]([C@@H](O4)C)N(C)C.

UNSPSC 51283222 Spiramycin i (Commodity) represents pharmaceutical supply procurement by state and local health agencies, though recent state and local contract opportunities show minimal activity directly aligned with this specific antibiotic. The code nominally covers spiramycin, a macrolide antibiotic, but the recent solicitations tagged to this code reflect broader pharmaceutical warehouse ordering and emergency health supplies rather than spiramycin-specific procurement. State and local governments buying under this commodity tier typically source through established pharmaceutical supply contracts, often piggybacked onto state or regional consortium frameworks such as MMCAP Infuse to secure volume pricing and streamlined procurement workflows. Issuing bodies include state departments of public health and county health departments managing both routine pharmaceutical stockpiles and emergency preparedness inventories.

Recent activity is sparse and geographically limited. Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for pharmaceutical warehouse supplies (Bid Number 26-482DPH-PREPD-B-53392), though that award covered Doxycycline Hyclate and Ciprofloxacin Hydrochloride rather than spiramycin. Seminole County, Florida released an IFB in June 2026 (IFB60459723LAS) for Naloxone and Safe Drug Deactivation Systems with a response deadline of July 26, 2023, seeking 1,900 units of Naloxone and 800 units annually through quarterly deliveries to the Seminole County Community Health Building. The mismatch between the code name and the actual goods being solicited suggests this commodity code sees limited relevant activity in current state and local procurement, or opportunities are being tagged inconsistently with their actual pharmaceutical scope.